Last update 04 Jun 2025

9-Valent HPV Vaccine(Xiamen Innovax)

Overview

Basic Info

Drug Type
Prophylactic vaccine
Synonyms-
Target-
Action-
Mechanism-
Therapeutic Areas
Infectious DiseasesNeoplasmsDigestive System Disorders+ [3]
Active Indication
Human Papillomavirus InfectionAnal intraepithelial neoplasiaCondylomata Acuminata+ [1]
Inactive Indication-
Originator Organization
Xiamen Innovax Biotech Co., Ltd.Xiamen Innovax Biotech Co., Ltd.
Active Organization
Xiamen Innovax Biotech Co., Ltd.Xiamen Innovax Biotech Co., Ltd.Xiamen UniversityXiamen University
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
First Approval Date
China (27 May 2025),
Human Papillomavirus Infection
RegulationPriority Review (China)
Login to view timeline

Related

1
Clinical Trials associated with 9-Valent HPV Vaccine(Xiamen Innovax)
NCT06866574
/ Not yet recruitingPhase 3IIT
A Multicenter, Randomized, Double-Blind, Aluminum Adjuvant-Controlled Phase III Clinical Trial to Evaluate the Efficacy, Immunogenicity, and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E. Coli) in Chinese Males Aged 18 to 45 Years
100 Clinical Results associated with 9-Valent HPV Vaccine(Xiamen Innovax)
Login to view more data
100 Translational Medicine associated with 9-Valent HPV Vaccine(Xiamen Innovax)
Login to view more data
100 Patents (Medical) associated with 9-Valent HPV Vaccine(Xiamen Innovax)
Login to view more data
100 Deals associated with 9-Valent HPV Vaccine(Xiamen Innovax)
Login to view more data

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Human Papillomavirus Infection
China
Xiamen Innovax Biotech Co., Ltd.Xiamen Innovax Biotech Co., Ltd.
27 May 2025
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Anal intraepithelial neoplasiaPhase 3
China
Xiamen Innovax Biotech Co., Ltd.Xiamen Innovax Biotech Co., Ltd.
31 Mar 2025
Condylomata AcuminataPhase 3
China
Xiamen Innovax Biotech Co., Ltd.Xiamen Innovax Biotech Co., Ltd.
31 Mar 2025
Penile NeoplasmsPhase 3
China
Xiamen Innovax Biotech Co., Ltd.Xiamen Innovax Biotech Co., Ltd.
31 Mar 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free